Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

GILD

DMG Mori (GILD)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GILD

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

Date	Time	Source	Headline	Symbol	Company
04/01/2011	3:30PM	Zacks	Gilead's Pact to Fight Cancer - Analyst Blog	NASDAQ:GILD	Gilead Sciences Inc
03/30/2011	9:38AM	Dow Jones News	Gilead Launches 4-Year Cancer Research Program With Yale	NASDAQ:GILD	Gilead Sciences Inc
03/30/2011	8:30AM	Business Wire	Yale and Gilead Sciences Announce Cancer Research Collaboration	NASDAQ:GILD	Gilead Sciences Inc
03/29/2011	9:20PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GILD	Gilead Sciences Inc
03/24/2011	5:10PM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(2) (424B2)	NASDAQ:GILD	Gilead Sciences Inc
03/24/2011	6:04AM	Edgar (US Regulatory)	Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)	NASDAQ:GILD	Gilead Sciences Inc
03/23/2011	7:54PM	Business Wire	Gilead Prices $1 Billion of Senior Unsecured Notes	NASDAQ:GILD	Gilead Sciences Inc
03/23/2011	2:29PM	Dow Jones News	UPDATE: Gilead Sciences Preps $1 Billion Bond Issue	NASDAQ:GILD	Gilead Sciences Inc
03/23/2011	10:05AM	Dow Jones News	Gilead Sciences Preps $1 Billion Bond Issue	NASDAQ:GILD	Gilead Sciences Inc
03/23/2011	9:12AM	Business Wire	Gilead to Offer Senior Notes	NASDAQ:GILD	Gilead Sciences Inc
03/23/2011	9:04AM	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(5) (424B5)	NASDAQ:GILD	Gilead Sciences Inc
03/23/2011	8:40AM	Edgar (US Regulatory)	Automatic shelf registration statement of securities of well-known seasoned issuers (S-3ASR)	NASDAQ:GILD	Gilead Sciences Inc
03/23/2011	8:30AM	Business Wire	Phase III Clinical Trial of Gilead’s Investigational Elvitegravir Meets 48-Week Primary Objective	NASDAQ:GILD	Gilead Sciences Inc
03/22/2011	4:54PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:GILD	Gilead Sciences Inc
03/22/2011	1:20PM	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:GILD	Gilead Sciences Inc
03/17/2011	7:26PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GILD	Gilead Sciences Inc
03/17/2011	7:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GILD	Gilead Sciences Inc
03/17/2011	7:24PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GILD	Gilead Sciences Inc
03/17/2011	7:23PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GILD	Gilead Sciences Inc
03/17/2011	7:22PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GILD	Gilead Sciences Inc
03/17/2011	7:22PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GILD	Gilead Sciences Inc
03/14/2011	8:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GILD	Gilead Sciences Inc
03/11/2011	4:45PM	Dow Jones News	Gilead CEO 2010 Compensation Valued At $14.2 Million	NASDAQ:GILD	Gilead Sciences Inc
03/11/2011	4:15PM	Business Wire	Gilead Recommends Rejection of Mini-Tender Offer By TRC Capital Corporation	NASDAQ:GILD	Gilead Sciences Inc
03/11/2011	3:08PM	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	NASDAQ:GILD	Gilead Sciences Inc
03/07/2011	8:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GILD	Gilead Sciences Inc
03/07/2011	4:30PM	Business Wire	Gilead Sciences to Present at Two Upcoming Investor Conferences	NASDAQ:GILD	Gilead Sciences Inc
03/04/2011	4:06PM	Dow Jones News	UPDATE: Gilead's Letairis Gets Safety Upgrade From FDA	NASDAQ:GILD	Gilead Sciences Inc
03/04/2011	9:41AM	Dow Jones News	Gilead: FDA Removes Potential Liver Injury Warnings On Letairis	NASDAQ:GILD	Gilead Sciences Inc
03/04/2011	9:31AM	PR Newswire (US)	Critical Alerts for Wells Fargo, Walgreens, Allstate, Gilead, and CIENA Released by Seven Summits Research	NASDAQ:GILD	Gilead Sciences Inc